Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 1;36(2):134-139.
doi: 10.1097/YCO.0000000000000840. Epub 2022 Dec 6.

Interventions for generalized anxiety disorder

Gerard J Byrne  1   2
Affiliations

Interventions for generalized anxiety disorder

Gerard J Byrne. Curr Opin Psychiatry. .

Abstract

Purpose of review: To provide an overview of recently published work on anxiety, focusing on generalized anxiety disorder (GAD) and its treatment.

Recent findings: Self-reported anxiety symptoms were highly prevalent during the COVID-19 global pandemic in both the general population and in selected groups. There remains divided opinion about whether internet-based cognitive behavioural therapy (CBT) is noninferior to face-to-face CBT for GAD. A systematic review of drug treatment for GAD showed efficacy for selective serotonin reuptake inhibitors (SNRIs), agomelatine, and quetiapine. There may be a place for repetitive transcranial magnetic stimulation in the treatment of GAD. There was some evidence of efficacy for complementary therapies, including physical exercise, yoga, acupuncture, and Withania somnifera (ashwagandha). However, a systematic review of cannabidiol and tetrahydrocannabinol found insufficient evidence of efficacy in anxiety disorders.

Summary: Antidepressants and quetiapine show efficacy in the treatment of GAD. Internet-based psychological interventions have a place in the treatment of GAD when face-to-face treatment is inaccessible. There is increasing evidence for the use of physical exercise in the management of GAD. Some other complementary therapies, including cannabinoids, require further, methodologically sound, research.

PubMed Disclaimer

References

    1. Yang X, Fang Y, Chen H, et al. Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019. Epidemiol Psychiatr Sci 2021; 30:e36.
    1. Thibodeau MA, Welch PG, Sareen J, Asmundson GJG. Anxiety disorders are independently associated with suicide ideation and attempts: propensity score matching in two epidemiological samples. Depress Anxiety 2013; 30:947–954.
    1. Delphino FM, da Silva CN, Jerônimo JS, et al. Prevalence of anxiety during the COVID-19 pandemic: a systematic review and meta-analysis of over 2 million people. J Affect Disord 2022; 318:272–282.
    1. Saeed H, Eslami A, Nassif NT, et al. Anxiety linked to COVID-19: a systematic review comparing anxiety rates in different populations. Int J Environ Res Public Health 2022; 19:2189.
    1. Johns G, Samuel V, Freemantle L, et al. The global prevalence of depression and anxiety among doctors during the COVID-19 pandemic: systematic review and meta-analysis. J Affect Disord 2022; 298 (Part A):431–441.

Publication types

MeSH terms